Pay in 4 interest-free payments of $6.74 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
GLP-1 receptor agonists like semaglutide (sold under brand names such as Ozempic, Rybelsus, and Wegovy) have recently gained attention for their role in helping people lose weight
PLoS One (2016) 11(7):e0160221
Quality assessment Potential risks of bias were evaluated for all included trials, using a tool for randomised trials (RoB 2) developed for this purpose.13 This tool assesses bias in five different domains: bias arising from the randomisation, bias due to deviations from the intended intervention, bias due to missing outcome data, bias in the measurement of the outcome and bias in the selection of the reported result
The reported results support that GLP1-RAs are an efficacious and safe option for the treatment of weight regain after bariatric surgery
US$ 23.55
US$ 26.76
US$ 22.74
